Synthesis and immunosuppressive activity of new cyclolinopeptide A analogs modified with β-prolines

Journal of Peptide Science

Volumn 14, Issue 12, 2008, Pages 1283-1294

  Katarzyńska, Joanna ^a   Mazur, Adam ^a   Bilska, Magdalena ^a   Adamek, Edyta ^a   Zimecki, Michał ^b   Jankowski, Stefan ^a   Zabrocki, Janusz ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

prolines; Cyclolinopeptide A; Immune response suppresors; NMR

Indexed keywords

CYCLO(BETA2 ISOPROLYL BETA2 ISOPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLO(BETA2 ISOPROLYLPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLO(BETA3 HOMOPROLINE BETA3 HOMOPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLO(BETA3 HOMOPROLYLPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLO(PROLINE BETA2 ISOPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLO(PROLINE BETA3 HOMOPROLYLPHENYLALANYLPHENYLALANYLLEUCYLISOLEUCYLISOLEUCYLEUCYLVALINE); CYCLOLINOPEPTIDE A DERIVATIVE; CYCLOSPORIN A; PEPTIDE DERIVATIVE; PROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; ERYTHROCYTE; FEMALE; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; ISOMERIZATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SHEEP; SPLEEN CELL; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIBODY FORMATION; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; PROLINE;

OVIS ARIES;

EID: 61849093773     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1069     Document Type: Article

References (53)

1. Ellis GP, West GB. Cyclosporins, fungal metabolites with immunosuppressive activities. Prog. Med. Chem. 1998: 25: 1-33.
2. Sigal NH, Dumont FJ, Cyclosporin A. FK-506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol. 1989; 10: 519-560.
3. Liu J, Albers MW, Luan TJ, Albert DG, Belshaw PJ, Cohen P, Macintosh C, Kee CB, Shreiber SL. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 1992: 31: 3896-3901.
4. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Shreiber SL. Calcuneurin is a common target of cyclophilin-cyclosporin A and FKBP-FK 506 complexes. Cell 1991; 66: 807-815.
5. Shreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991: 251: 283-287.
6. McCaffrey PG, Perrino BA, Sorderling TR, Rao A. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J. Biol. Chem. 1993: 268: 3747-3752.
7. Prox A, Weygand F. Sequenzanalyse von peptiden durch kombination von gas chromatographie und massen spectrometrie. In Peptides, Proceedings 8th European Peptide Symposium, Beyerman HC, van de Linde A, Maasen van den Brink W (eds). North-Holland: Amsterdam, 1967; 158-172.
8. Kaufmann HP, Tobschirbel A. Ueber ein oligopeptid aus leinsamen: Chem. Ber. 1959: 92: 2805-2809.
9. Wieczorek Z, Bengtsson B, Trojnar J, Siemion IZ. Immunosuppressive activity of Cyclolinopeptide A. Pept. Res. 1991; 4: 275-283.
10. Siemion IZ, Cebrat M, Wieczorek Z. Cyclolinopeptide and their analogs - a new family of peptide immunosuppressants affecting the calcineurin system. Arch. Immunol. Ther. Exp. 1999; 47: 143-153.
11. Gaymes TJ, Cebrat M, Siemion IZ, Kay JE. Cyclolinopeptide Z (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation. FEBS Lett. 1997; 418: 224-227.
12. Benedetti E, Pedone C. Cyclolinopeptide A: inhibitor, immunosuppressor or other? J. Pept. Sci. 2005; 11: 268-272.
13. Picur B, Cebrat M, Zabrocki J, Siemion IZ. Cyclopeptides of Linum usitatissimum. J. Pept. Sci. 2006; 12: 569-574.
14. Siemion IZ, Pçdyczak A, Strug I, Wieczorek Z. Synthesis and biological studies on analogs of Cyclolinopeptide A with a shortened peptide chain. Arch. Immunol. Ther. Exp. 1994; 42: 459-465.
15. Zubrzak P, Leplawy MT, Kowalski ML, Szkudlińska B, Paneth P, Sillbering J, Suder P, Zabrocki J. Correlating biological activity with calculated geometric motifs in cyclolinopeptide A analogs. J. Phys. Org. Chem. 2004; 17: 625-630.
16. Siebach D, Beck AK, Bierbaum DJ. The world of β- and γ-peptides comprised of homologated proteinogenic amino acids and other components. Chem. Biodivers. 2004; 1: 1111-1239.
17. Rossi F, Bucci E, Isernia C, Saviano M. Iacovino R, Romanelli A, Di Lello P, Grimaldi M, Monteserchio D, De Napoli L, Piccaialli G, Benedetti E. Effect of lengthening of peptide backbone by insertion of chiral β-homo amino acid residues: conformational behaviour of linear peptides containing alternating L-leucine and β-homo L-lucine residues. Biopolymers 2000; 53: 140-149.
18. Schumann F, Müller A, Koksch M, Müller G, Sewald N. Are β-aminoacids γ-turn mimetics? Exploring a new design principle for bioactive cyclopeptides. J. Am. Chem. Soc. 2000; 122: 12009-12010.
19. Malešević M, Majer Z, Vass E, Huber T, Strijkowski U, Hollósi M, Sewald N. Spectroscopic detection of pseudo-turns in homodetic cyclic penta- and hexapeptides comprising β-homoproline. Int. J. Pept. Res. Ther. 2006; 12: 165-177.
20. Klein SI, Czekaj M, Molino BF, Chu V. Constrained β-alanine based GpIIb/IIIa antagonists. Bioorg. Med. Chem. Lett. 1997; 7/ 13: 1773-1778.
21. Cardillo G, Gentilucci L, Melchiorre P, Spampinato S. Synthesis and binding activity of endomorphin-1 analogues containing β-amino acids. Bioorg. Med. Chem. Lett. 2000; 10: 2755-2758.
22. Hashimoto M, Eda Y, Osanai Y, Iwai T, Aoki S. A novel decarboxylation of α-amino acids. A facile method of decarboxylation by the use of 2-cyclohexen-1-one as a catalyst. Chem. Lett. 1986; 15: 893-896.
23. Cardillo G, Gentilucci L, Qasem AR, Sgarzi F, Spampinato S. Endomorphin-1 analogues containing β-proline are μ-opioid receptor agonists and display enhance enzymatic hydrolysis resistance. J. Med. Chem. 2002; 45: 2571-2578.
24. Naqvi T, Bhattacharya M, Haq W. An efficient method for the reduction of N-protected amino acids and peptides to the corresponding alcohols. J. Chem. Res. (S) 1999; 7: 424-425.
25. Marfey P. Determination of D-amino adds. II. Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg Res. Commun. 1984; 49: 591-596.
26. Bhushan R, Brückner H. Marfey's reagent for chiral amino acid analysis: A review. Amino Acids 2004; 27: 231-247.
27. Di Blasio B, Rossi F, Benedetti E, Pavone V, Pedone C, Temussi PA, Zanotti G, Tancredi T. Bioactive peptides: solid-state and solution conformation of Cyclolinopeptide A. J. Am. Chem. Soc. 1989; 111: 9089-9098.
28. Kessler H. Conformation and biological activity of cyclic peptides. Angew. Chem., Int. Ed. Engl. 1982; 21: 512-523.
29. Petro TM, Schwartz KM, Chen SS. Production of IL-2 and IL-13 in syngeneic mixed lymphocyte reactions of BALB/c mice are elevated during a period of moderate dietary protein deficiency. Immunol. Invest. 1994; 23: 143-152.
30. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995: 6: 277-293.
31. Keller R The Computer Aided Resonance Assignment Tutorial. Cantina Verlag: Goldau, 2004.
32. Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J. Magn. Reson. 2003; 160: 66-74.
33. Schwieters CD, Kuszewski JJ, Clore GM. Using Xplor-NIH for NMR molecular structure determination. Prog. Nucl. Magn. Reson. Spectrosc. 2006; 48: 47-62.
34. Lindahl E, Hess BA, van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Mod. 2001: 7: 306-317.
35. van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: fast, flexible and free. J. Comput. Chem. 2005; 26: 1701-1719.
36. Oostenbrink C, Villa A, Mark AE, van Gunsteren WF. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS Force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 2004: 25: 1656-1676.
37. Berendsen HJC, Postma JPM, DiNola A, Haak JR. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984; 81: 3684-3690.
38. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J. Chem. Phys. 1995; 103: 8577-8592.
39. Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977; 23: 327-341.
40. Trzesniak D, Glattli A, Jaun B, van Gunsteren WF. Interpreting NMR data for β-peptides using molecular dynamics simulations. J. Am. Chem. Soc. 2005: 127: 14320-14329.
41. Naylor A, Judd DB, Scopes DJC, Hayes AG, Birch PJ. 4-[(Alkylamino)methyl]furo[3,2-c]pyridines: a new series of selective [s K s]-receptor agonist. J. Med. Chem. 1994; 37: 2138-2144.
42. Ohtake H, Imada Y, Murahashi SI. Regioselective synthesis of nitrones by decarboxylative oxidation of N-alkyl-α-amino acids and application to the synthesis of 1-azabicyclic alkaloids. Bull. Chem. Soc. Jpn. 1999; 72: 2737-2754.
43. Cardillo G, Gentilucci L, Tolomelli A, Calienni M, Qasem AR, Spampinato S. Stability against enzymatic hydrolysis of endomorphin-1 analogues containing β-proline. Org. Biomol. Chem. 2003; 1: 1498-1502.
44. Thomas CH, Orecher F, Gmeiner P. A practical ex-chiral-pool synthesis of β-proline and homo-β-proline. Synthesis 1998: 1491-1496.
45. Braghiroli D, Avallone R, Di Bella M. Asymmetric synthesis of (R)- and (S)-2-pyrrolidinemethanesulfonic acid. Tetrahedron: Asymmetry 1997: 8: 2209-2213.
46. Busson R, Vanderhaeghe H. Synthesis and circular dichroism of (5S]-1-azabicyclo[3.2.0]heptan-7-one. J. Org. Chem. 1978; 43: 4438-4441.
47. Rano TA, Chapman KT. Solid phase synthesis of aryl ethers 40 via Mitsunobu reaction. Tetrahedron Lett. 1995; 36: 3789-3792.
48. Richter LS, Gadek TR. A surprising observation about Mitsunobu-reactions in solid phase synthesis. Tetrahedron Lett. 1994 35: 4705-4706.
49. Kaiser E, Colescot RL, Bossinger CD, Cook PI. Color test for detection of free amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970: 34: 595-598.
50. Vojkovsky T. Detection of secondary-amines on solid-phase. Pept. Res. 1995: 8: 236-237.
51. Hansen MB, Nielsen SE, Berg KJ. Re-examination and further development of a precise rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989; 119: 203-210.
52. Mishell RI, Dutton RW. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 1967: 126: 423-442.
53. Espevik T, Nissan-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 1986; 95: 99-105.